With the SCs, a greater proportion of moderate or strong IgG (p = 0.0348) and IgM (p = 0.0121) antibody reactivities were observed in the sera of patients with ZIKV-GBS compared with other patients with uncomplicated ZIKV and control groups (Table 1). The gene discussed is CD40LG; the disease is Guillain-Barre syndrome.